A robust process for the manufacture of the active pharmaceutical ingredient (API) amodiaquine dihydrochloride dihydrate (ADQ, ), an important antimalarial, is reported. The process consists of a three-step synthetic route that involves a Mannich reaction, substitution with 4,7-dichloroquinoline (4,7-DCQ, ), and rehydration. Additionally, a cost-competitive process for the production of 4,7-DCQ () is also reported wherein 4,7-DCQ () was prepared in four steps from -chloroaniline ().
View Article and Find Full Text PDF